## Abstract ## Purpose: To optimize the timing of contrast‐enhanced magnetic resonance imaging (MRI) that best indicates blood–brain barrier (BBB) disruption induced by focused ultrasound (FUS) along with an ultrasound contrast agent (UCA) and to verify that the contrast‐enhanced spin‐echo MRI seq
Dextran-magnetite particles: Contrast-enhanced MRI of blood–brain barrier disruption in a rat model
✍ Scribed by Jeff W. M. Bulte; Martinus W. A. de Jonge; Richard L. Kamman; K. Gwan Go; Fred Zuiderveen; Bert Blaauw; John A. Oosterbaan; T. Hauw; Lou de Leij
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 653 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Dextran‐magnetite particles (DMP) were studied for their use as a MR contrast agent to visualize lesions with a blood‐brain barrier (bbb) disruption. A freezing injury to the rat cerebral cortex was used as a model of bbb disruption. The biodistribution of iv‐injected DMP was studied using atomic absorption spectrophotometry, electron microscopy, and MRI. One hour after injection, focal accumulation of the particles in capillary endothelial cells could be demonstrated in the freezing lesion. Despite the observation that the relaxivity of DMP in vivo appears to be less well pronounced than that in vitro, the MR imaging studies show that DMP can be used to visualize bbb disruption with adequate contrast. © 1992 Academic Press, Inc.
📜 SIMILAR VOLUMES
## Abstract Breakdown of the blood‐brain barrier (BBB), occurring in many neurological diseases, has been difficult to measure noninvasively in humans. Dynamic contrast‐enhanced magnetic resonance imaging measures BBB permeability. However, important technical challenges remain and normative data f